Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Change in Accured Expenses (2016 - 2025)

Altimmune (ALT) has disclosed Change in Accured Expenses for 16 consecutive years, with $4.4 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 83.59% to $4.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, up 2233.04% year-over-year, with the annual reading at $2.4 million for FY2025, 2233.04% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $4.4 million at Altimmune, up from $102000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $11.0 million in Q3 2021, with the low at -$9.2 million in Q4 2021.
  • Average Change in Accured Expenses over 5 years is $174400.0, with a median of -$950000.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses soared 835.0% in 2021, then tumbled 392.0% in 2024.
  • Over 5 years, Change in Accured Expenses stood at -$9.2 million in 2021, then surged by 76.54% to -$2.2 million in 2022, then soared by 165.82% to $1.4 million in 2023, then surged by 66.55% to $2.4 million in 2024, then surged by 83.59% to $4.4 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $4.4 million, $102000.0, and -$365000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.